Efficacy and safety of Tafolecimab in Chinese patients with type 2 diabetes and hypercholesterolemia: a post-hoc analysis of pooled data from three phase 3 trials.
Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop.
Amiodarone for atrial fibrillation following cardiac surgery: development of clinical practice guidelines at a university hospital.
Durability of class I American College of Cardiology/American Heart Association clinical practice guideline recommendations.
Critical appraisal of guidelines for coronary artery disease on dual antiplatelet therapy: More consensus than controversies.
Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3.
ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine.
